retatrutide phase 2 study results Trial of for Obesity ESC 2024: Retatrutide improves lipid

May your vials stay potent, your storage stay cold, and your protocols stay consistent.

Choose injectable or oral compounded GLP-1

Use an alcohol swab to clean the top of the vial and another to clean your skin where you plan to inject

Both medications require careful patient monitoring due to potential interactions

Contraindications may include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, a history of pancreatitis, and other conditions

However, the participants in the STEP study were severely overweight with an average BMI of 37~38kg/, and the clinical trial was conducted according to overall Western obesity standards